A revision of a group standard is quietly reshaping the technology balance of the sanitary products industry chain. Released in August 2026, T/CIAA 008—2026 for antimicrobial sanitary pads, pantyliners and period pants officially introduces the concept of "long-lasting antimicrobial (bacteriostatic)", requiring products to maintain antibacterial function under simulated use conditions. This is not just a terminology addition; it rewrites the verification logic from raw materials to finished products.
Core Logic of the Standard Upgrade
The most significant change is the expanded definition. The original "bacteriostatic sanitary pads" has been adjusted to "antimicrobial sanitary pads, pantyliners and period pants", incorporating period pants for the first time. Behind this expansion lies the diversification of female menstrual care products—the period pants market has grown rapidly but lacked a unified evaluation basis for antibacterial performance. This revision fills the gap and provides clear compliance pathways for manufacturers.
More impactful is the introduction of "long-lasting antimicrobial" performance. The standard requires that products be tested by adding bovine serum albumin to the skin-contact layer and placing them at (36±1)°C for no less than 8 hours, simulating actual use, after which they must still exhibit antimicrobial effects. This test simulates body temperature and secretion environments, meaning that the static "factory-fresh" indicator is no longer sufficient; products must withstand post-use scrutiny. For R&D departments, this directly forces optimization of formulations and material systems.
Industry Transmission: From Nonwovens to Antimicrobial Agents
The ripple effect on upstream materials is immediate. Nonwoven fabrics used for the surface and absorbent layers will have their fiber structure and finishing processes directly impact long-lasting bacteriostasis. Ordinary impregnation of antimicrobial agents may be effective initially, but after 8 hours of simulation, active ingredients may leach out and fail. Therefore, slow-release antimicrobial agents, microencapsulation technology, and intrinsic modification of antimicrobial fibers will become key R&D directions.
Antimicrobial agent suppliers also face challenges. The introduction of bovine serum albumin as a simulated contaminant requires agents to maintain activity under organic interference, demanding broader-spectrum and more stable performance. Testing laboratories need to upgrade equipment and personnel capabilities to handle the new long-lasting efficacy test methods. The technical threshold across the supply chain is systematically raised, potentially accelerating the elimination of small and medium enterprises lacking R&D reserves.
Practical Impact on Buyers and Factories
The revision directly affects procurement decisions. Brands will no longer rely solely on routine bacteriostasis rate reports but will require data on long-lasting efficacy. This may extend procurement cycles and increase testing costs, but it brings product differentiation and consumer trust. For export-oriented companies, alignment with GB 15979-2024 helps reduce technical barriers in international trade.
Factory-side adjustments are more urgent. Production lines need to verify whether existing processes can meet the long-lasting requirement, possibly requiring new antimicrobial finishing equipment or adjustments to post-treatment steps. Quality departments must rebuild internal control indicators, incorporating long-lasting bacteriostasis into outgoing inspection items. Notably, the standard is managed by Zhongguancun Huizhi Antimicrobial New Material Industry Technology Innovation Alliance, with drafting units including Guangdong Institute of Microbiology (Guangdong Microbial Analysis and Testing Center) and SGS (Shanghai), indicating strong technical support and credibility.
Industry Trends and Outlook
The revision sends a clear signal: evaluation of antimicrobial performance in sanitary products is shifting from "static labels" to "dynamic efficacy". This aligns with consumers' increasingly stringent expectations for health products. It is foreseeable that other disposable hygiene products (e.g., diapers, wet wipes) may adopt similar logic, driving the industry toward higher quality. For the textile industry, nonwoven and antimicrobial material suppliers should closely monitor standard developments and prepare technology reserves to stay ahead in the next round of competition.